Nature Immunology SJR and Scopus Metrics: What the Numbers Actually Tell Authors
Nature Immunology remains one of the strongest primary-research immunology journals in the Scopus system. The useful question is whether your paper is decisive enough for it.
Associate Professor, Immunology & Infectious Disease
Author context
Specializes in manuscript preparation and peer review strategy for immunology and infectious disease research, with 10+ years evaluating submissions to top-tier journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: Nature Immunology remains one of the strongest primary-research immunology journals under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 10.390, a CiteScore of 38.2, and stable Q1 standing. That confirms major specialist prestige, but the submission decision still depends on whether the manuscript is decisive enough to change how immunologists interpret a mechanism or disease process.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 10.390 | Prestige-weighted influence is exceptionally strong for immunology |
CiteScore | 38.2 | Four-year citation performance is elite |
SNIP | 3.810 | Field-normalized impact is also strong |
Quartile | Q1 | The journal remains firmly top-tier |
Category standing | Top immunology title | The journal sits near the top of specialist immunology |
JCR context | Impact factor 27.6 | Web of Science tells the same flagship story |
The useful reading is that Nature Immunology is not only a well-known brand. It remains one of the journals that defines what elite primary immunology looks like.
What the metrics actually help with
They help explain where the journal sits:
- above most specialist immunology venues in prestige-weighted influence
- strong enough to travel outside pure immunology into infection, inflammation, and cancer biology
- still a very different editorial target from broader review-heavy or society-journal ecosystems
That is useful when you are deciding between Nature Immunology, another top specialist journal, and a broader cross-field target.
What the metrics do not answer
They do not tell you:
- whether the mechanism is complete enough
- whether the paper is too local to one model or niche
- whether the story is still too descriptive
- whether the manuscript is broad enough to matter outside one immune subcommunity
Those are still the real fit questions.
Why the profile matters for authors
At this SJR level, Nature Immunology can be unforgiving with near-miss manuscripts. The journal's profile reflects a specific editorial product:
- mechanistic immunology that feels decisive
- evidence strong enough to survive hard scrutiny
- field consequences that travel across immunology
- papers that other researchers keep citing because they reshape interpretation
That is why the numbers are useful. They show the journal has enough real authority that it does not need to be generous with merely competent or promising work.
What should drive the submission decision instead
The better question is whether the manuscript is truly a Nature Immunology paper.
That is why the better next reads are:
- Is Nature Immunology a good journal?
- Nature Immunology submission guide
- Nature Immunology submission process
- Nature Immunology impact factor
If the work is still too descriptive, too local, or too dependent on framing rather than evidence, the metrics do not rescue the mismatch. They only explain why the journal's screen stays severe.
Practical verdict
Nature Immunology has a genuine flagship specialist Scopus profile. That makes it an exceptional target when the manuscript is mechanistically decisive, broadly relevant, and mature enough to withstand a demanding primary-immunology screen.
But the author takeaway should still be about fit, not prestige. If the paper is truly field-moving, the upside is huge. If it is still one mechanistic layer short, the metric is already warning you. A free Manusights scan is the fastest way to pressure-test that before submission.
- Is Nature Immunology a good journal?, Manusights.
Sources
- 1. Nature Immunology journal browser entry, University of Twente journal browser.
- 2. Nature Immunology journal page, Nature Portfolio.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Nature Chemical Biology Submission Guide: What to Prepare Before You Submit
- How to Avoid Desk Rejection at Nature Chemical Biology
- Is Nature Chemical Biology a Good Journal? Fit Verdict
- Nature Neuroscience 'Under Consideration': Status Meanings and Timeline
- Nature Pre-Submission Checklist: Is Your Paper Ready for the World's Top Journal?
- Nature Chemical Biology Submission Process: What Happens After Upload
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.